OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
LCBH52

Luxchem Corporation Bhd

Commodity ChemicalsVerified

Luxchem Corporation Bhd maintains a strong liquidity position with a current ratio of 4.59, indicating the company can cover its short-term liabilities more than four times over. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints despite the high current ratio. The debt-to-equity ratio of 0.12 suggests a conservative capital structure with limited leverage. Profitability metrics show a return on equity (ROE) of 2.22% and a return on assets (ROA) of 1.57%, both below the typical thresholds for high-performing chemical distributors. These figures indicate that the company is generating modest returns relative to its equity and asset base. The operating margin, calculated as operating income of MYR 21.25 million on revenue of MYR 210.20 million, is 10.1%, which is in line with the industry median for commodity chemical distributors. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and supply chain disruptions. The absence of segment-specific revenue breakdowns in the latest financial filing limits the ability to assess the performance of individual product lines or customer bases. Looking ahead, the company is projected to maintain a stable revenue trajectory, with no significant growth or contraction expected in the next fiscal year. Capital expenditures have been negative in the latest period, suggesting a focus on cost optimization rather than expansion. The company's free cash flow of MYR 18.24 million indicates it is generating sufficient cash to support operations and potentially fund dividends or share repurchases. Risk factors include the company's reliance on a single business model and the potential for dilution if the company issues additional shares. The risk assessment indicates a low probability of dilution in the near term, but the company's capital structure leaves room for future equity issuance if needed. The company's liquidity risk is rated as medium, primarily due to the negative net cash position after accounting for total debt. Recent filings and transcripts do not indicate any material changes in the company's business strategy or financial outlook. The company continues to operate within its core chemical distribution and trading activities, with no disclosed plans for significant new ventures or market expansions.

30-day price · LCBH+0.05 (+12.7%)
Low$0.35High$0.40Close$0.40As of12 May, 00:00 UTC
Profile
CompanyLuxchem Corporation Bhd
TickerLCBH.KL
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. (unavailable from LLM output)

Classification. (unavailable from LLM output)

Luxchem Corporation Bhd maintains a strong liquidity position with a current ratio of 4.59, indicating the company can cover its short-term liabilities more than four times over. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints despite the high current ratio. The debt-to-equity ratio of 0.12 suggests a conservative capital structure with limited leverage. Profitability metrics show a return on equity (ROE) of 2.22% and a return on assets (ROA) of 1.57%, both below the typical thresholds for high-performing chemical distributors. These figures indicate that the company is generating modest returns relative to its equity and asset base. The operating margin, calculated as operating income of MYR 21.25 million on revenue of MYR 210.20 million, is 10.1%, which is in line with the industry median for commodity chemical distributors. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and supply chain disruptions. The absence of segment-specific revenue breakdowns in the latest financial filing limits the ability to assess the performance of individual product lines or customer bases. Looking ahead, the company is projected to maintain a stable revenue trajectory, with no significant growth or contraction expected in the next fiscal year. Capital expenditures have been negative in the latest period, suggesting a focus on cost optimization rather than expansion. The company's free cash flow of MYR 18.24 million indicates it is generating sufficient cash to support operations and potentially fund dividends or share repurchases. Risk factors include the company's reliance on a single business model and the potential for dilution if the company issues additional shares. The risk assessment indicates a low probability of dilution in the near term, but the company's capital structure leaves room for future equity issuance if needed. The company's liquidity risk is rated as medium, primarily due to the negative net cash position after accounting for total debt. Recent filings and transcripts do not indicate any material changes in the company's business strategy or financial outlook. The company continues to operate within its core chemical distribution and trading activities, with no disclosed plans for significant new ventures or market expansions.
Key takeaways
  • Luxchem Corporation Bhd maintains a conservative capital structure with a debt-to-equity ratio of 0.12.
  • The company's ROE of 2.22% and ROA of 1.57% indicate modest profitability relative to its equity and asset base.
  • Revenue is concentrated in a single business segment, increasing exposure to regional and supply chain risks.
  • Free cash flow of MYR 18.24 million supports operational flexibility and potential shareholder returns.
  • The company's liquidity risk is rated as medium due to a negative net cash position after total debt.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyMYR
Revenue$210.2M
Gross profit$31.8M
Operating income$21.3M
Net income$12.2M
R&D
SG&A
D&A
SBC
Operating cash flow$13.1M
CapEx-$1.6M
Free cash flow$18.2M
Total assets$774.8M
Total liabilities$226.2M
Total equity$548.5M
Cash & equivalents
Long-term debt$63.1M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$924.3M$98.2M$68.2M$35.3M
FY-3$802.8M$71.9M$45.7M$1.8M
FY-2$653.5M$60.3M$37.1M$29.5M
FY-1$795.4M$82.4M$48.0M$40.4M
FY0$731.0M$70.9M$41.8M$23.9M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$791.5M$489.8M
FY-3$717.7M$512.7M
FY-2$740.4M$533.5M
FY-1$821.5M$564.0M
FY0$803.7M$585.5M
PeriodOCFCapExFCFSBC
FY-4$39.4M-$7.7M$35.3M
FY-3$122.2M-$40.4M$1.8M
FY-2$62.9M-$9.9M$29.5M
FY-1$14.1M-$15.1M$40.4M
FY0$83.9M-$21.1M$23.9M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$210.2M$21.3M$12.2M$18.2M
FQ-6$196.1M$11.7M$6.7M$1.9M
FQ-5$205.9M$30.5M$17.6M$12.2M
FQ-4$190.1M$17.7M$10.6M-$428.6k
FQ-3$187.7M$14.4M$8.9M$7.0M
FQ-2$174.1M$15.9M$9.8M-$1.6M
FQ-1$179.0M$22.9M$12.5M$18.9M
FQ0$177.2M$21.4M$13.2M-$25.1M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$774.8M$548.5M
FQ-6$754.5M$545.8M
FQ-5$821.5M$564.0M
FQ-4$785.4M$562.6M
FQ-3$761.0M$571.1M
FQ-2$766.8M$573.3M
FQ-1$803.7M$585.5M
FQ0$787.8M$588.1M
PeriodOCFCapExFCFSBC
FQ-7$13.1M-$1.6M$18.2M
FQ-6$5.6M-$2.6M$1.9M
FQ-5$14.1M-$15.1M$12.2M
FQ-4$17.8M-$5.5M-$428.6k
FQ-3$55.1M-$11.9M$7.0M
FQ-2$77.1M-$20.9M-$1.6M
FQ-1$83.9M-$21.1M$18.9M
FQ0$2.3M-$34.1M-$25.1M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$548.5M
Net cash-$63.1M
Current ratio4.6
Debt/Equity0.1
ROA1.6%
ROE2.2%
Cash conversion1.1%
CapEx/Revenue-0.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricLCBHActivity
Op margin10.1%5.5% medp25 -0.0% · p75 10.8%above median
Net margin5.8%4.1% medp25 0.1% · p75 8.8%above median
Gross margin15.1%20.5% medp25 12.4% · p75 29.7%below median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-0.8%-6.2% medp25 -13.4% · p75 -2.6%top quartile
Debt / equity12.0%37.1% medp25 10.3% · p75 82.0%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 10:23 UTC#929bdf33
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 09:46 UTCJob: 56a2ccdf